Now I have all the data I need to write the article.
Short sellers are pulling back from some of Wall Street's most-watched names. But in biotech and micro-caps, bearish pressure is hitting new highs.
GME short interest dipped to 13.6% of free float. That's down from 14.3% a week ago. Shorts are quietly covering. MSTR tells a similar story — SI eased to 10.8% from 11%.
Netflix saw the sharpest cover among large caps. SI dropped from 2.1% to 1.9% in a week. Strong earnings momentum appears to be scaring bears away.
The standout mover in the other direction: Avis Budget Group. Its SI collapsed from 86% to 69% — a dramatic 17-point drop. Bears are fleeing fast.
In biotech, the squeeze looks brutal. KalVista Pharmaceuticals sits at 71% SI with 18 days-to-cover. Neurogene is at 79%. holds 64%. All three have low availability — refuelling any squeeze could prove very difficult for new shorts.
Sensei Biotherapeutics tops the overall short leaderboard at 116% of free float. Its cost-to-borrow has surged to 234% APR. Entering a new short here is extremely expensive.
Among micro-caps, Hitek Global saw the biggest weekly SI jump — up 108 percentage points to 145%. Thinly traded names like this can move violently in either direction.
This note is for informational purposes only and does not constitute financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
